MMP-2 regulates Src activation via repression of the CHK/MATK tumor suppressor in osteosarcoma

Deanna V Maybee1, Christopher R Cromwell2, Basil P Hubbard2

  • 1Department of Pharmaceutical Sciences, SUNY Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, New York, USA.

PubMed
Abstract

Insights

Matrix metalloproteinase-2 (MMP-2) suppresses tumor suppressor CHK/MATK, promoting osteosarcoma cell migration. Targeting MMP-2 may enhance doxorubicin treatment effectiveness and reduce chemoresistance by restoring CHK/MATK expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Doxorubicin is a primary osteosarcoma treatment, but chemoresistance and enhanced cell migration at sublethal doses are concerns.
  • Matrix metalloproteinase-2 (MMP-2) degrades extracellular matrix, promoting metastasis, and its nuclear form regulates gene expression.
  • Src kinase, crucial for metastasis, is inhibited by Csk and Csk homologous kinase (CHK/MATK).

Purpose of the Study:

  • To investigate the role of MMP-2 in regulating Src kinase activity in osteosarcoma.
  • To determine if MMP-2 acts as an upstream regulator of Src kinase by affecting its inhibitor, CHK/MATK.

Main Methods:

  • Investigated the relationship between MMP-2 and CHK/MATK in osteosarcoma cells.
  • Assessed the impact of MMP-2 gene inactivation and CHK/MATK overexpression on doxorubicin-induced cell migration.

Main Results:

  • MMP-2 gene acts as an upstream regulator of Src kinase by suppressing CHK/MATK expression in osteosarcoma.
  • Inactivating MMP-2 or overexpressing CHK/MATK counteracted doxorubicin-induced osteosarcoma cell migration.
  • MMP-2 suppresses both gene and protein expression of the tumor suppressor CHK/MATK.

Conclusions:

  • MMP-2 is a key suppressor of CHK/MATK in osteosarcoma, driving cancer cell migration.
  • Targeting MMP-2 offers a promising strategy to combat osteosarcoma cell migration and metastasis.
  • Inhibiting MMP-2 may enhance doxorubicin efficacy and overcome chemoresistance in osteosarcoma treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K